Johnson & Johnson
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson Full-Year Guidance — Operational sales midpoint by Quarter
Full-Year Guidance — Operational sales midpoint ($B)
Johnson & Johnson Full-Year Guidance — Operational sales midpoint: $100.70B in Q3 2026, up 8.0% from a year earlier. That is the highest of the 17 quarters on record here.
Where the Q3 2026 figure comes from
“|| Operational Sales 2 / Mid-point Change vs. Prior Year / Mid-point | $100.5B – $100.9B /$100.7B 6.7% – 7.1% / 6.9% | $100.3B – $100.9B / $100.6B 6.5% – 7.1% / 6.8%”
Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Reported in Form 8-K EX-99.1 Full-Year Guidance Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Johnson & Johnson Full-Year Guidance — Operational sales midpoint, quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/guid-ops-sales-mid-b
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.